The reaction of anhydrous YCl3 with an equimolar amount of lithium N,N'-diisopropyl-N' '-bis(trimethylsilyl)guanidinate, Li[(Me3Si)2NC(Ni-Pr)2], in tetrahydrofuran (THF) afforded the monomeric monoguanidinate dichloro complex {(Me3Si)2NC(Ni-Pr)2}YCl2(THF)2 (1). Alkylation of complex 1 with 2 equiv of LiCH2SiMe3 in hexane at 0 degrees C yielded the monomeric salt-free dialkyl complex {(Me3Si)2NC(Ni-Pr)2}Y(CH2SiMe3)2(THF)2 (2). The bis(triethylborohydride) complex [(Me3Si)2NC(Ni-Pr)2]Y[(mu-H)(mu-Et)2BEt]2(THF) (5) was prepared by the reaction of complex 1 with 2 equiv of LiBEt3H in a toluene-THF mixture at 0 degrees C. The complexes 1, 2, and 5 were structurally characterized. Complex 2 as well as the systems 2-Ph3B, 2-Ph3B-MAO, and 1-MAO (MAO = methylaluminoxanes) in toluene were inactive in ethylene polymerization, while the product obtained in situ from the reaction of complex 2 with a 2-fold molar excess of PhSiH3 in toluene polymerized ethylene with moderate activity.
No takes yet. Share an insight, caveat, or question.
Lyubov et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: